Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,214 total articles
Viasat, Inc., a global satellite communications company, announced its first quarter financial results for fiscal year 2027. The company provides a shareholder letter and webcast slides on its investor relations website and will host a conference call to discuss the results.
PROCEPT BioRobotics reported a 19% revenue increase to $94.5 million in Q2 2026 driven by growth in U.S. system and consumable sales, with 21% more procedures completed and 65 new HYDROS system placements. The company achieved strategic milestones including completing enrollment in a prostate cancer study and reinforcing Aquablation therapy's recom…
GigaCloud Technology Inc announced that its CFO, Erica Wei, will participate in one-on-one virtual meetings with investors at the Oppenheimer 29th Annual Technology, Internet & Communications Conference. The company operates a global B2B ecommerce platform facilitating cross-border transactions primarily between Asian manufacturers and resellers in…
Sonoco Products Company announced a strategic realignment of its Global Consumer Packaging businesses under a single leadership structure led by Ernest Haynes, aiming to leverage efficiencies across its metal and paper packaging operations, which generate about $5.2 billion in annual sales. This move is intended to enhance collaboration, innovation…
American Well Corporation (Amwell) reported second quarter 2026 total revenue of $52.0 million, hitting the top of its guidance range, with subscription revenue nearing half of total revenue. The company improved its adjusted EBITDA loss guidance for 2026 and reaffirmed visit and revenue targets, anticipating positive operating cash flow in Q4 2026…
OrthoPediatrics Corp. announced a 15% year-over-year increase in second quarter 2026 revenue to $70.5 million, driven by strong growth in the Trauma & Deformity product line and international markets. The company reported improved adjusted EBITDA of $6.8 million and reduced free cash flow usage by 78%. It increased its full-year 2026 revenue guidan…
Weyco Group, Inc. announced robust second quarter 2026 financial results with net sales up 7% year-over-year to $62.2 million, and net earnings increasing significantly to $13.3 million from $2.3 million in Q2 2025. The substantial improvement was driven largely by the recognition of $15.3 million in tariff refunds following a U.S. Supreme Court ru…
Suja Life, a natural better-for-you beverage company traded on NASDAQ under SUJA, reported Q2 2026 net sales up 11.6% to $83.9 million driven by volume growth and new product distribution. The company posted a larger net loss of $27.8 million, impacted by $25.1 million of one-time IPO-related transaction costs and debt extinguishment losses, but ad…
Opendoor Technologies delivers a strong Q2 2026, exceeding guidance across acquisitions, revenue, margin, and EBITDA metrics. Revenue grew 23% quarter-over-quarter, contribution profit up 59%, and homes purchased surged 77%. Marketing spend was drastically reduced while acquisition contracts increased to nearly 6,900. The company projects becoming …
BlackLine, Inc. reported its Q2 2026 earnings, showing a 9.2% increase in GAAP revenues to $187.8 million and improved operating margins. The company highlighted accelerated adoption of AI-powered Verity agents, driving revenue growth and platform conversion. Customer demand remains strong despite longer sales cycles due to rigorous AI evaluations.…
Tenaya Therapeutics announced its participation in the Canaccord Genuity 46th Annual Growth Conference, including a 1x1 investor meeting and a fireside chat featuring CFO Eric Hyllengren. The company is a clinical-stage biotech focused on developing gene and small molecule therapies targeting genetic heart diseases and related conditions.
Globus Maritime Limited, a dry bulk shipping company listed on NASDAQ, announced its annual meeting of shareholders will be held on September 17, 2026, in Glyfada, Greece. Shareholders of record as of July 20, 2026, are entitled to vote. The company operates nine dry bulk vessels worldwide with a combined capacity of over 680,000 deadweight tons.
Workhorse Group Inc., a US industrial technology company specializing in electrification and mobility platforms, announced the grant of 56,250 restricted stock units to a new non-executive employee as an inducement for joining the company, in compliance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over three years, subject to continued e…
Vroom, Inc. reported its second quarter 2026 financial results, marking the first quarter of positive net income and adjusted net income in the company's history. The company continues investing in its Next-Generation Technology Platform, supported by improvements in its internal customer scoring model at United Auto Credit Corporation (UACC). Vroo…
Spyre Therapeutics announced positive topline Phase 2 induction data from its SKYLINE trial showing best-in-class efficacy and safety for its IBD drug candidates SPY001 and SPY002. It completed enrollment ahead of schedule for the SKYWAY Phase 2 basket trial in rheumatic diseases, with multiple proof-of-concept data readouts expected in 2026. The c…
Credit Acceptance Corporation announced its second quarter 2026 financial results, showcasing solid growth in net income, adjusted net income, and economic profit compared to the same period in 2025. The company highlighted sustained profitability, a $8.0 billion loan portfolio balance, and advancements in its AI-enabled, digital-first strategy to …
Leonardo DRS, Inc. announced a new agreement to establish a 141,087-square-foot facility in Brookfield, Connecticut, consolidating its Naval Power Systems business from three locations. The move aims to enhance operational efficiency, support increased demand for naval nuclear propulsion programs, and position the company for growth in the evolving…
Dianthus Therapeutics highlights significant progress in its clinical development programs for severe autoimmune diseases, including initiation of a Phase 3 trial for claseprubart in generalized Myasthenia Gravis with top-line results expected in late 2028, promising interim Phase 3 CIDP trial data, and enrollment completion in the Phase 2 MMN tria…
Skyward Specialty Insurance Group, Inc. reported solid second quarter 2026 results featuring a 17.5% increase in managed premiums, 13.3% growth in gross written premiums, and an improved combined ratio of 89.5%. The company also expanded its share repurchase program and demonstrated strong returns with annualized operating ROE of 20.4% for the firs…
Milestone Pharmaceuticals, a biopharmaceutical company specializing in cardiovascular medicines, announced it will release its Q2 2026 financial results on August 12, followed by a business update and investor conference call. The company focuses on innovative treatments including its FDA-approved CARDAMYST nasal spray for certain heart arrhythmias…
Flywire Corporation announced robust second quarter 2026 results with a 27.2% year-over-year revenue increase to $167.7 million and a 44.5% rise in adjusted EBITDA to $24 million. The company raised its FY 2026 guidance for FX-neutral revenue growth and EBITDA margin expansion, supported by strong client wins, geographic diversification, and produc…
Capital Southwest Corporation is urging shareholders to support a proposal to increase the number of its authorized shares of common stock from 75 million to 135 million. The company highlights that this move is not associated with an immediate capital raise but is intended to preserve flexibility to pursue future investment opportunities that alig…
Security National Financial Corporation announced that it will hold its Q2 2026 earnings call on August 13, 2026, at 1 PM MDT. The 30-minute call will review quarterly financial results and updates from the company’s three business segments, with a possible Q&A session if time permits. Investors are encouraged to preregister for the webcast through…
Pacira BioSciences posted solid second quarter 2026 financial results with total revenues of $192.4 million, a 6% year-over-year increase, and GAAP net income of $4.7 million. The company successfully completed the divestiture of its iovera® business to Zimmer Biomet, receiving $73.6 million upfront and potential further milestones. Advancements in…
Syndax Pharmaceuticals reported robust financial results for Q2 2026, with total revenue of $73 million, driven by 91% year-over-year growth in Revuforj net revenue and 67% growth in Niktimvo net revenue. The company advanced its clinical pipeline including novel therapies for non-small cell lung cancer (NSCLC) and myelofibrosis (MF), with multiple…
